Meplazumab
Meplazumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Meplazumab is a humanized anti-CD147 antibody being investigated as an add-on therapy in patients with COVID-19 pneumonia.
| Trade Name | Meplazumab |
| Generic | Meplazumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
How Meplazumab works
Meplazumab is an anti-CD147 antibody, which is a recepor on host cells for viruses such as SARS-CoV2. Meplazumab's inhibition of CD147 binding to the spike proteins of viruses is thought to inhibit their entry.
Innovators Monograph
You find simplified version here Meplazumab
